Skip to main content

Table 2 Cohen's Kappa results of intermethod and interviewers assessments

From: Accuracy of telepsychiatric assessment of new routine outpatient referrals

    

Standard vs Video

Interviewers

SN

Primary Attributes

Size

Group

CK

LCI

UCI

CK

LCI

UCI

1

DSM-IV Axis 1

54

26

0.90

0.28

1.00

0.90

0.33

1.00

2

DSM-IV Axis 2

37

2

0.62

-0.04

0.87

0.63

0.21

0.87

3

DSM-IV Axis 3

38

2

0.84

0.49

0.93

0.84

0.49

0.93

4

DSM-IV Axis 4 Q1

37

2

0.57

0.25

0.82

0.57

0.22

0.83

5

DSM-IV Axis 4 Q2

37

2

0.17

-0.11

0.72

0.18

-0.09

0.68

6

DSM-IV Axis 4 Q3

37

2

0.85

0.66

0.91

0.85

0.66

0.91

7

DSM-IV Axis 4 Q4

37

2

0.87

0.65

0.94

0.87

0.65

0.94

8

DSM-IV Axis 4 Q5

37

2

0.66

NA

NA

0.66

NA

NA

9

DSM-IV Axis 4 Q6

37

2

0.55

0.18

0.84

0.54

0.13

0.84

10

DSM-IV Axis 4 Q8

37

2

0.36

-0.07

0.79

0.37

-0.08

0.54

11

DSM-IV Axis 5

37

5

0.89

0.81

0.94

0.89

0.81

0.94

12

Risk to self Q1

37

3

0.66

0.39

0.86

0.65

0.39

0.86

13

Risk to self Q2

37

3

0.68

0.34

0.86

0.68

0.37

0.86

14

Risk to self Q3

37

3

0.55

-0.11

0.73

0.55

0.22

0.80

15

Risk to self Q4

37

3

0.45

-0.11

0.68

0.45

0.12

0.79

16

Risk to others Q1

37

3

0.62

0.27

0.86

0.62

0.27

0.86

17

Risk to others Q2

37

3

0.82

0.30

1.00

0.82

0.37

1.00

18

Risk to others Q3

37

2

-0.04

-0.10

-0.03

-0.04

-0.10

-0.03

19

Risk to others Q4

37

3

0.55

-0.11

0.78

0.55

-0.06

0.78

20

Risk to others Q5

37

2

0.44

-0.07

0.84

0.44

-0.06

0.84

21

Risk to others Q6

37

3

0.41

-0.13

0.66

0.41

-0.12

0.66

22

Admit-Discharge-Follow up

37

3

0.76

0.37

0.93

0.76

0.37

0.93

23

Investigations

37

2

0.29

-0.03

0.59

0.30

-0.02

0.59

24

Psychological Input

37

2

0.16

-0.17

0.53

0.18

-0.12

0.54

25

Community Support

37

2

0.55

0.22

0.78

0.56

0.25

0.78

26

Drug Type

75

9

0.83

0.61

0.90

0.82

0.52

0.90

27

Drug Action

75

5

0.67

0.52

0.79

0.66

0.52

0.79

28

Drug Indication

75

11

0.59

0.35

0.74

0.59

0.35

0.76

Main Attributes

29

DSM-IV Axis 1 (1)

54

26

0.90

0.28

1.00

0.90

0.33

1.00

30

DSM-IV Axis 2 (2)

37

2

0.62

-0.04

0.87

0.63

0.21

0.87

31

DSM-IV Axis 3 (3)

38

2

0.84

0.49

0.93

0.84

0.49

0.93

32

DSM-IV Axis 4 (4:10)

259

14

0.65

0.52

0.78

0.65

0.52

0.78

33

DSM-IV Axis 5 (11)

37

5

0.89

0.81

0.94

0.89

0.81

0.94

34

Risk to self (12:15)

148

12

0.61

0.48

0.75

0.61

0.48

0.75

35

Risk to Others (16:21)

222

16

0.05

-0.01

0.11

0.05

-0.01

0.11

36

Admit-Discharge-Follow up (22)

37

3

0.76

0.37

0.93

0.76

0.37

0.93

37

Investigations (23)

37

2

0.29

-0.03

0.59

0.30

-0.02

0.59

38

Psychological Input (24)

37

2

0.16

-0.17

0.53

0.18

-0.12

0.54

39

Community Support (25)

37

2

0.55

0.22

0.78

0.56

0.25

0.78

40

Drug Type (26)

75

9

0.83

0.61

0.90

0.82

0.52

0.90

41

Drug Action (27)

75

5

0.67

0.52

0.79

0.66

0.52

0.79

42

Drug Indication (28)

75

11

0.59

0.35

0.74

0.59

0.35

0.76

Major Attributes

43

DSM-IV (1:11)

425

49

0.86

0.81

0.90

0.86

0.81

0.90

44

Risks (12:21)

370

28

0.14

0.08

0.19

0.14

0.09

0.19

45

Non-Drug Intervention (22:25)

148

9

0.49

0.35

0.64

0.49

0.35

0.64

46

Drug Intervention (26:28)

225

25

0.72

0.66

0.79

0.72

0.66

0.79

Overall

47

Overall Result (1:28)

1168

111

0.60

0.57

0.63

0.60

0.57

0.63

  1. The column 'Size' constitutes the number of total sample points used for assessments.
  2. The column 'Group' stands for the number of total categories of results e.g. all diagnoses with Paranoid Schizophrenia will make one group.
  3. CK: Cohen's Kappa values derived from 'n by n' table made from the Groups. The significant values (Lower CI more than 0) are printed in bold. The summary CK results in the rows from 29 to 47 are based on "Inverse Variance method" using CKs and variances from previous rows displayed in the brackets for the respective assessments.
  4. 95% Lower & Upper Confidence Intervals (LCI and UCI) from the rows 1 to 28 are derived from non-parametric Bias Corrected Accelerated (BCa) variance from 50,000 bootstrap samples with replacement. The summary LCIs and UCIs in the rows from 29 to 47 are based on "Inverse Variance method" using CKs and original variances from previous rows are displayed in the brackets for the respective assessments.
  5. Weighted Kappa using "square error weights" were computed for ordinal observations where applicable.
  6. The definitions for Drug Type, Drug Action and Drug Indication are same as in the Table 1.